Table
2: Comparison
of MSC and fibroblast characteristics.
A. Surface marker expressions |
|||
Features |
Criteria |
References |
|
Marker |
MSC |
Fibroblasts |
|
CD73 |
Present |
Present |
|
CD105 |
Present |
Present |
|
CD90 |
Present |
Present |
|
CD44 |
Present |
Present |
|
CD49b |
Present |
Present |
[66]
|
CD20 |
Absent |
Absent |
[64]
|
CD45 |
Absent |
Absent |
|
CD34 |
Absent |
Absent |
|
CD11a |
Absent |
Absent |
[66]
|
CD14 |
Absent |
Absent |
|
HLA-DR |
Absent |
Absent |
|
CD34 |
Absent |
Absent |
|
CD117 |
Absent |
Absent |
[66]
|
CD133 |
Absent |
Absent |
[43]
|
CD33 |
Absent |
Absent |
[66]
|
CD31 |
Absent |
Absent |
|
CD10 |
Present |
Absent |
[66]
|
CD26 |
Present |
Absent |
[66]
|
CD54 |
Present |
Absent |
[67]
|
CD106 |
Present |
Absent |
|
CD146 |
Present |
Absent |
|
ITGA11 |
Present |
Absent |
[63]
|
B. Multi-lineage differentiation and
proliferation strength |
|||
Features |
Criteria |
References |
|
Potency |
MSC |
Fibroblasts |
|
Osteogenesis |
Present |
Present |
[68]
|
Adipogenesis |
Present |
Present |
|
Chondrogenesis |
Present |
Present |
|
Colony-forming potential |
Present |
Absent |
[48]
|